Ingevity Corporation (NYSE: NGVT) today announced that it will
hold a live webinar to review and discuss its Industrial
Specialties and Oilfield Technologies businesses on June 11, 2020,
at 10 a.m. (Eastern Time). This is the third event in a previously
announced webinar series that will serve to educate analysts and
investors about its businesses.
Presenters will include Mike Smith, executive vice president and
president, Performance Chemicals; Nick Kob, vice president,
Oilfield Technologies; and Rich White, vice president, Industrial
Specialties. John Fortson, executive vice president, chief
financial officer and treasurer, will also be available for
questions.
The Industrial Specialties/Oilfield Technologies webinar will be
conducted via webcast and can be accessed through Ingevity’s
Investor Relations site, or via this link: Ingevity Industrial
Specialties/Oilfield Technologies webinar.
This event will also be accessible by teleconference by dialing
877-407-2991 (inside the U.S.) or 201-389-0925 (outside the U.S.),
at least 10 minutes prior to the start of the event.
For those unable to join the live event, a replay of the webinar
will be available beginning at approximately 2 p.m. (Eastern Time)
on June 11, 2020, through July 11, 2020, at: Ingevity Industrial
Specialties/Oilfield Technologies webinar replay.
Information on how to access the webinar and teleconference,
along with a slide deck containing other relevant business
information, will be posted to the investors section of Ingevity’s
website at www.ingevity.com prior to the call.
For a full list of upcoming webinars in this series, please see
the press release issued by Ingevity on March 24, 2020.
Ingevity: Purify, Protect and Enhance
Ingevity provides specialty chemicals, high-performance carbon
materials and engineered polymers that purify, protect and enhance
the world around us. Through a team of talented and experienced
people, Ingevity develops, manufactures, and brings to market
products and processes that help customers solve complex problems.
These products are used in a variety of demanding applications,
including asphalt paving, oil exploration and production,
agrochemicals, adhesives, lubricants, publication inks, coatings,
elastomers, bioplastics and automotive components that reduce
gasoline vapor emissions. Headquartered in North Charleston, South
Carolina, Ingevity operates from 25 locations around the world and
employs approximately 1,850 people. The company is traded on the
New York Stock Exchange (NYSE: NGVT). For more information visit
www.ingevity.com.
Cautionary Statements About Forward-Looking
Statements
This press release contains “forward-looking statements” within
the meaning of the Securities Exchange Act of 1934, as amended, and
the Private Securities Litigation Reform Act of 1995. Such forward
looking statements generally include the words “may,” “could,”
“should,” “believes,” “plans,” “intends,” “targets,” “will,”
“expects,” “suggests,” “anticipates,” “outlook,” “continues,”
“forecast,” “prospect,” “potential” or similar expressions.
Forward-looking statements may include, without limitation,
expected financial positions, results of operations and cash flows;
financing plans; business strategies and expectations; operating
plans; impact of coronavirus; synergies and the potential benefits
of the acquisition of Perstorp Holding AB’s Capa® caprolactone
business (the “acquisition”); capital and other expenditures;
competitive positions; growth opportunities for existing products;
benefits from new technology and cost-reduction initiatives, plans
and objectives; markets for securities and expected future
repurchases of shares, including statements about the manner,
amount and timing of repurchases. Like other businesses, Ingevity
is subject to risks and uncertainties that could cause its actual
results to differ materially from its expectations or that could
cause other forward-looking statements to prove incorrect. Factors
that could cause actual results to materially differ from those
contained in the forward-looking statements, or that could cause
other forward-looking statements to prove incorrect, include,
without limitation, adverse effects from the COVID-19 pandemic;
risks that the expected benefits from the acquisition may not be
realized or will not be realized in the expected time period, the
risk that the acquired business will not be integrated successfully
and the risk of significant transaction costs and unknown or
understated liabilities; adverse effects of general economic and
financial conditions; risks related to international sales and
operations; impacts of currency exchange rates and currency
devaluation; compliance with U.S. and foreign regulations
concerning our operations outside the U.S.; changes in trade
policy, including the imposition of tariffs; the impact of the
United Kingdom’s withdrawal from the European Union; attracting and
retaining key personnel; adverse conditions in the global
automotive market or adoption of alternative and new technologies;
competition from producers of alternative products and new
technologies, and new or emerging competitors; competition from
infringing intellectual property activity; worldwide air quality
standards; a decrease in government infrastructure spending;
declining volumes and downward pricing in the printing inks market;
the limited supply of or lack of access to sufficient crude tall
oil; a prolonged period of low energy prices; the provision of
services by third parties at several facilities; natural disasters,
such as hurricanes, winter or tropical storms, earthquakes,
tornados, floods, fires; other unanticipated problems such as labor
difficulties, equipment failure or unscheduled maintenance and
repair; protection of intellectual property and proprietary
information; information technology security breaches and other
disruptions; complications with designing and implementing our new
enterprise resource planning system; government policies and
regulations, including, but not limited to, those affecting the
environment, climate change, tax policies, tariffs and the
chemicals industry; and lawsuits arising out of environmental
damage or personal injuries associated with chemical or other
manufacturing processes. These and other important factors that
could cause actual results or events to differ materially from
those expressed in forward-looking statements that may have been
made in this document are and will be more particularly described
in our filings with the U.S. Securities and Exchange Commission,
including our Form 10-K for the year ended December 31, 2019 and
our other periodic filings. Readers are cautioned not to place
undue reliance on Ingevity’s projections and forward-looking
statements, which speak only as the date thereof. Ingevity
undertakes no obligation to publicly release any revision to the
projections and forward-looking statements contained in this press
release, or to update them to reflect events or circumstances
occurring after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200528005790/en/
Laura Woodcock
843-746-8197 laura.woodcock@ingevity.com
Investors: Dan
Gallagher 843-740-2126 daniel.gallagher@ingevity.com
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Apr 2023 to Apr 2024